
Ambrx Biopharma Investor Relations Material
Latest events

Investor Day 2023
Ambrx Biopharma

Q3 2023
13 Nov, 2023

Corporate Presentation
6 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ambrx Biopharma Inc
Access all reports
Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of antibody drug conjugates (ADCs) and other engineered therapies aimed at modulating the immune system. The company is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AMAM
Country
🇺🇸 United States